5HVF | Hydrolase Hydrolase Inhibitor | date | Jan 28, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Thrombin-Activatable Fibrinolysis Inhib Complex With An Inhibitory Nanobody (Vhh-I83) | ||||||||||||||
authors | X.Zhou, S.D.Weeks, S.V.Strelkov, P.J.Declerck | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Carboxypeptidase B2 Chain: A Fragment: Unp Residues 23-423 Synonym: Carboxypeptidase U,Cpu,Plasma Carboxypeptidase B,P Thrombin-Activable Fibrinolysis Inhibitor,Tafi; Ec: 3.4.17.20 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Cpb2 Expression_system: Pichia Pastoris Expression_system_taxid: 4922 Expression_system_strain: M5 Expression_system_vector_type: Plasmid Expression_system_plasmid: Ppic9 | ||||||||||||||
Molecule: Vhh-I83 Chain: B Engineered: Yes |
Organism_scientific: Vicugna Pacos Organism_common: Alpaca Organism_taxid: 30538 Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 Expression_system_strain: Rosetta2 Plyss Expression_system_vector_type: Plasmid Expression_system_plasmid: Pethsuk | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.85 Å | ||||||||||||
ligand | BMA, FLC, MAN, NAG, ZN | enzyme | Hydrolase E.C.3.4.17.20 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Elucidation of the molecular mechanisms of two nanobodies that inhibit TAFI activation and TAFIa activity., Zhou X, Weeks SD, Ameloot P, Callewaert N, Strelkov SV, Declerck PJ, J Thromb Haemost. 2016 Jun 9. doi: 10.1111/jth.13381. PMID:27279497 |
Data retrieval |
View 5HVF in 3D |
Visual 3D analysis of 5HVF |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5HVF |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |